Vident Advisory’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.89M Buy
34,486
+3,445
+11% +$259K 0.02% 511
2025
Q4
$2.08M Sell
31,041
-48
-0.2% -$3.1K 0.02% 569
2025
Q3
$2.1M Buy
31,089
+1,011
+3% +$73.3K 0.02% 563
2025
Q2
$2.24M Sell
30,078
-3,999
-12% -$266K 0.03% 467
2025
Q1
$2.14M Buy
34,077
+12,137
+55% +$750K 0.03% 461
2024
Q4
$1.25M Buy
21,940
+837
+4% +$49.5K 0.02% 563
2024
Q3
$1.24M Buy
21,103
+111
+0.5% +$6.06K 0.03% 549
2024
Q2
$1.13M Sell
20,992
-584
-3% -$32.2K 0.03% 551
2024
Q1
$1.24M Buy
21,576
+2,981
+16% +$154K 0.03% 515
2023
Q4
$891K Sell
18,595
-364
-2% -$17.4K 0.02% 595
2023
Q3
$970K Buy
+18,959
New +$1M 0.03% 517

Other funds holding CTVA

Vident Advisory's CTVA Position: Q1 2026 in Review

Vident Advisory increased its Corteva (CTVA) stake by 11% in Q1 2026, buying an estimated $259K and bringing the position to 34,486 shares worth $2.89M. The position accounts for 0.02% of the portfolio, ranked #511.

Vident Advisory first reported a position in CTVA in Q3 2023 and has held it in 11 quarters since. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Vident Advisory held 34,486 shares of Corteva worth $2.89M as of Q1 2026.
  • Vident Advisory bought 3,445 Corteva shares in Q1 2026, an estimated $259K.
  • Corteva made up 0.02% of Vident Advisory's portfolio in Q1 2026, its #511 holding.
  • Vident Advisory first reported a position in Corteva in Q3 2023 and has held it in 11 quarters since.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.